Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated UrsodiolWith Unmodif ...